Cervical cancer is the fourth most common female cancer in the world, with the vast majority (95%) of cases attributed to human papillomavirus (HPV). In Greece, new HPV cases are estimated at 700 per year and deaths due to HPV at 300 per year. Having the upgrading of Public Health as one of its strategic priorities, Bodossaki Foundation supports the Hellenic Foundation of Oncology by donating a total number of 1,000 reactors for Pap tests. The tests will be performed with the new Liquid-based Pap test (Thin Prep) method, followed by the HPV identification process.
1,000 HPV detection reactors
Grantee
Hellenic Foundation of Oncology
The Hellenic Foundation of Oncology is a non-profit public benefit foundation, established by the Hellenic Anticancer Institute and the Hellenic Oncological Society to promote the growing activities involved in the early detection and treatment of cancer. The official operation of the Hellenic Foundation of Oncology started on 1 March 2000. As part of its activities, more than 465,000 women have so far been examined completely free of charge, by undergoing a mammogram and a Pap smear test, thus shielding their health. All examinations carried out under the programme, as well as any repeat examinations where necessary, are offered to women free of charge, with no financial, insurance or tax related eligibility requirements for participation.
